Skip to main content
Top
Published in: Calcified Tissue International 4/2018

01-10-2018 | Original Research

Periprosthetic Bone Mineral Density Around Uncemented Titanium Stems in the Second and Third Decade After Total Hip Arthroplasty: A DXA Study After 12, 17 and 21 Years

Authors: David S. Peitgen, Moritz M. Innmann, Christian Merle, Tobias Gotterbarm, Babak Moradi, Marcus R. Streit

Published in: Calcified Tissue International | Issue 4/2018

Login to get access

Abstract

Implant failure and periprosthetic fractures because of periprosthetic bone loss are a major concern in total hip arthroplasty (THA). Hardly any clinical data exist on the long-term evolution of bone mineral density (BMD) around uncemented femoral implants. The question to address is whether relevant bone loss continues into third decade around well-fixed uncemented femoral implants. BMD around stable uncemented straight titanium femoral implants was assessed in a longitudinal cohort study. We included 142 hips of 128 patients and measured the development of the periprosthetic BMD using dual-energy X-ray absorptiometry. The baseline measurement was 12 years (t1) after the implantation of an uncemented femoral stem. Follow-up-measurements were performed at 17 (t2) and at 21 years (t3) after primary THA. The regions of interest (ROI) were selected conforming to Gruen et al. We acquired complete data including three consecutive measurements (t1, t2, t3) for 42 patients (49 hips). Performing radiographic evaluation at t1, t2 and t3, we found a regular bone-implant interface present in all cases. Significant decrease in BMD could be shown in ROI 1 (p = 0.0001; − 7.8%), 4 (p = 0.024; − 2.4%), 6 (p = 0.001; − 5.5%) and 7 (p < 0.0001; − 11.7%) between t1 and t3 and in ROI 1 (p = 0.002; − 3.7%), 2 (p = 0.046; − 3.6%), 4 (p = 0.002; − 2.7%) and 7 (p < 0.0001; − 8.0%) between t2 and t3. There were significant differences in overall bone density (netavg) between t1 and t3 (p = 0.001; − 3.6%) and between t2 and t3 (p = 0.020; − 2.1%). The data indicate clinically relevant changes of BMD especially in the proximal Gruen zones in the long-term after uncemented THA. Loss of periprosthetic BMD might be a risk factor for periprosthetic fractures.
Literature
4.
go back to reference Grappiolo G, Burastero G, Moraca G, Camera A, Santoro G, Gruen T, Spotorno L (2009) The CLS stem in primary THA. Long-term results and survivorship analysis of a tapered, grit-blasted, press-fit femoral prosthesis. J Bone Joint Surg 91-B(SUPP I):51 Grappiolo G, Burastero G, Moraca G, Camera A, Santoro G, Gruen T, Spotorno L (2009) The CLS stem in primary THA. Long-term results and survivorship analysis of a tapered, grit-blasted, press-fit femoral prosthesis. J Bone Joint Surg 91-B(SUPP I):51
8.
go back to reference Rahmy AI, Gosens T, Blake GM, Tonino A, Fogelman I (2004) Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss. Osteoporos Int 15(4):281–289. https://doi.org/10.1007/s00198-003-1546-5 CrossRefPubMed Rahmy AI, Gosens T, Blake GM, Tonino A, Fogelman I (2004) Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss. Osteoporos Int 15(4):281–289. https://​doi.​org/​10.​1007/​s00198-003-1546-5 CrossRefPubMed
10.
go back to reference Braun A, Papp J, Reiter A (2003) The periprosthetic bone remodelling process–signs of vital bone reaction. Int Orthop 27(Suppl 1):S7-10PubMed Braun A, Papp J, Reiter A (2003) The periprosthetic bone remodelling process–signs of vital bone reaction. Int Orthop 27(Suppl 1):S7-10PubMed
15.
go back to reference Gruen TA, McNeice GM, Amstutz HC (1979) “Modes of failure” of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res 141:17–27 Gruen TA, McNeice GM, Amstutz HC (1979) “Modes of failure” of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res 141:17–27
16.
go back to reference Willert HG, Bertram H, Buchhorn GH (1990) Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res 258:95–107 Willert HG, Bertram H, Buchhorn GH (1990) Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res 258:95–107
17.
go back to reference Engh CA, Bobyn JD, Glassman AH (1987) Porous-coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg 69(1):45–55CrossRef Engh CA, Bobyn JD, Glassman AH (1987) Porous-coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg 69(1):45–55CrossRef
18.
go back to reference Gibbons CE, Davies AJ, Amis AA, Olearnik H, Parker BC, Scott JE (2001) Periprosthetic bone mineral density changes with femoral components of differing design philosophy. Int Orthop 25(2):89–92CrossRefPubMedPubMedCentral Gibbons CE, Davies AJ, Amis AA, Olearnik H, Parker BC, Scott JE (2001) Periprosthetic bone mineral density changes with femoral components of differing design philosophy. Int Orthop 25(2):89–92CrossRefPubMedPubMedCentral
19.
go back to reference Sychterz CJ, Engh CA (1996) The influence of clinical factors on periprosthetic bone remodeling. Clin Orthop Relat Res 322:285–292CrossRef Sychterz CJ, Engh CA (1996) The influence of clinical factors on periprosthetic bone remodeling. Clin Orthop Relat Res 322:285–292CrossRef
20.
go back to reference Kroger H, Venesmaa P, Jurvelin J, Miettinen H, Suomalainen O, Alhava E (1998) Bone density at the proximal femur after total hip arthroplasty. Clin Orthop Relat Res 352:66–74 Kroger H, Venesmaa P, Jurvelin J, Miettinen H, Suomalainen O, Alhava E (1998) Bone density at the proximal femur after total hip arthroplasty. Clin Orthop Relat Res 352:66–74
21.
go back to reference Nishii T, Sugano N, Masuhara K, Shibuya T, Ochi T, Tamura S (1997) Longitudinal evaluation of time related bone remodeling after cementless total hip arthroplasty. Clin Orthop Relat Res 339:121–131CrossRef Nishii T, Sugano N, Masuhara K, Shibuya T, Ochi T, Tamura S (1997) Longitudinal evaluation of time related bone remodeling after cementless total hip arthroplasty. Clin Orthop Relat Res 339:121–131CrossRef
23.
go back to reference Venesmaa PK, Kröger HP, Miettinen HJ, Jurvelin JS, Suomalainen OT, Alhava EM (2001) Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry—a 3-year follow-up study. J Bone Miner Res 16(6):1056–1061CrossRefPubMed Venesmaa PK, Kröger HP, Miettinen HJ, Jurvelin JS, Suomalainen OT, Alhava EM (2001) Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry—a 3-year follow-up study. J Bone Miner Res 16(6):1056–1061CrossRefPubMed
24.
go back to reference Kröger H, Miettinen H, Arnala I, Koski E, Rushton N, Suomalainen O (1996) Evaluation of periprosthetic bone using dual-energy X-ray absorptiometry: precision of the method and effect of operation on bone mineral density. J Bone Miner Res 11(10):1526–1530CrossRefPubMed Kröger H, Miettinen H, Arnala I, Koski E, Rushton N, Suomalainen O (1996) Evaluation of periprosthetic bone using dual-energy X-ray absorptiometry: precision of the method and effect of operation on bone mineral density. J Bone Miner Res 11(10):1526–1530CrossRefPubMed
25.
go back to reference Karachalios T, Tsatsaronis C, Efraimis G, Papadelis P, Lyritis G, Diakoumopoulos G (2004) The long-term clinical relevance of calcar atrophy caused by stress shielding in total hip arthroplasty: a 10-year, prospective, randomized study1 1No benefits or funds were received in support of this study. J Arthroplast 19(4):469–475CrossRef Karachalios T, Tsatsaronis C, Efraimis G, Papadelis P, Lyritis G, Diakoumopoulos G (2004) The long-term clinical relevance of calcar atrophy caused by stress shielding in total hip arthroplasty: a 10-year, prospective, randomized study1 1No benefits or funds were received in support of this study. J Arthroplast 19(4):469–475CrossRef
29.
go back to reference World-Health-Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Org Tech Rep Ser 843:1-129 World-Health-Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Org Tech Rep Ser 843:1-129
Metadata
Title
Periprosthetic Bone Mineral Density Around Uncemented Titanium Stems in the Second and Third Decade After Total Hip Arthroplasty: A DXA Study After 12, 17 and 21 Years
Authors
David S. Peitgen
Moritz M. Innmann
Christian Merle
Tobias Gotterbarm
Babak Moradi
Marcus R. Streit
Publication date
01-10-2018
Publisher
Springer US
Published in
Calcified Tissue International / Issue 4/2018
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-018-0438-9

Other articles of this Issue 4/2018

Calcified Tissue International 4/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine